NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE
NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.
-
Treatment for men with enlarged prostate is recommended by NICE for NHS adoption
Final guidance from NICE recommends the PLASMA system
-
NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
-
Shared decision making is an integral part of healthcare, says NICE
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
